Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 8 | |
Outperform | 5 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for MoonLake Immunotherapeutics have a median target of 71.50, with a high estimate of 104.00 and a low estimate of 40.00. The median estimate represents a 33.12% increase from the last price of 53.71.
High | 93.6% | 104.00 |
Med | 33.1% | 71.50 |
Low | -25.5% | 40.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -26.38% |
Average growth rate | +57.06% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼